Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludrocortisone Addition to Dexamethasone in Hospitalised COVID-19
NCT05453214Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Dec 2021
- Primary completion
- Mar 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fludrocortisone in coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS), sponsored by Ain Shams University. Started Dec 2021; status: completed.
02
Drugs
fludrocortisone
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT05453214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05453214.